Metabolic inhibitors increase prolactin binding to cultured mammary tumor cells.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism*
D004140:Dinitrophenols; D011956:Receptors, Cell Surface; D001414:Bacitracin; D015127:9,10-Dimethyl-1,2-benzanthracene; D002738:Chloroquine; D011388:Prolactin